Trials / Terminated
TerminatedNCT00823420
Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneuploidy Rate and Developmental Potential
Influence of a Prematuration Culture With a PDE3-I on Embryonic Aneuploidy Rate and Developmental Potential
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 213 (actual)
- Sponsor
- Universitair Ziekenhuis Brussel · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
A single centre randomised controlled trial investigating the influence of a novel prematuration system (PMS) using a phosphodiesterase-3 inhibitor for in-vitro maturation of oocytes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | prematuration culture | The aneuploidy rate and the developmental potential of embryos obtained from PDE3 inhibitor-treated oocytes (a "prolonged" IVM (PMC)) in comparison to "conventional" IVM will be analysed. It is intended to assess the nuclear and cytogenetic constitution of the obtained embryos. |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2009-01-15
- Last updated
- 2014-12-05
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00823420. Inclusion in this directory is not an endorsement.